F H Corstens
Overview
Explore the profile of F H Corstens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
171
Citations
1402
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gotthardt M, Broker S, Schlieck A, Bauhofer A, Herbst B, Behe M, et al.
Nuklearmedizin
. 2007 Aug;
46(4):135-40.
PMID: 17690791
Aim: Ultrasound may be a cheap alternative to scintigraphic determination of splenic function. We directly compared nanocolloid scintigraphy (NS), scintigraphy with heat-altered erythrocytes (ES), and colour-coded Doppler sonography (DS) in...
2.
Gotthardt M, Rubner C, Bauhofer A, Berce F, Oyen W, Goecke J, et al.
Nuklearmedizin
. 2006 Oct;
45(5):206-12.
PMID: 17043731
Purpose: Dose calculation for radioiodine therapy (RIT) of multifocal autonomies (MFA) is a problem as therapeutic outcome may be worse than in other kinds of autonomies. We compared different dosimetric...
3.
Hoogendoorn E, Wiersinga W, Prummel M, den Heijer M, Corstens F, Hermus A
Ned Tijdschr Geneeskd
. 2004 May;
148(19):953-4.
PMID: 15160563
Subclinical hyperthyroidism is defined as the presence of serum free thyroxine (T4) and triiodothyronine (T3) levels within the reference range and a reduced serum thyrotrophin (TSH) level. Evidence is accumulating...
4.
Janssen M, Pels W, Massuger L, Oyen W, Boonstra H, Corstens F, et al.
Int J Gynecol Cancer
. 2003 Dec;
13(5):607-13.
PMID: 14675343
Despite debulking surgery and multidrug chemotherapy, advanced stage ovarian cancer has a high mortality rate. Radioimmunotherapy (RIT) is a treatment modality using specific, radiolabeled antibodies that guide cytotoxic radionuclides to...
5.
Rennen H, Oyen W, CAIN S, Monk P, Corstens F, Boerman O
Nucl Med Biol
. 2003 May;
30(3):267-72.
PMID: 12745018
Unlabelled: The complement anaphylatoxin C5a and its natural metabolite C5a des Arg(74) (C5adR) are involved in several stages of the inflammatory process. Both act on a common receptor expressed on...
6.
Boerman O, Rennen H, Oyen W, Corstens F
Semin Nucl Med
. 2001 Nov;
31(4):286-95.
PMID: 11710771
Scintigraphic imaging of infection and inflammation is a powerful diagnostic tool in the management of patients with infectious or inflammatory diseases. Most infectious and inflammatory foci can be visualized accurately...
7.
Postema E, Boerman O, Oyen W, Raemaekers J, Corstens F
Eur J Nucl Med
. 2001 Nov;
28(11):1725-35.
PMID: 11702116
In the past decade, several new antibody-based therapies - using either radiolabelled or unlabelled monoclonal antibodies - have become available for the treatment of patients with refractory or recurrent non-Hodgkin's...
8.
Nieuwlaat W, Hermus A, Sivro-Prndelj F, Corstens F, Huysmans D
J Clin Endocrinol Metab
. 2001 Nov;
86(11):5330-6.
PMID: 11701700
In a recent study, we demonstrated that pretreatment with a single, low dose of recombinant human TSH (rhTSH) doubles 24-h thyroid radioactive iodine uptake in patients with nodular goiter. The...
9.
Boerman O, Oyen W, Corstens F
Eur J Nucl Med
. 2001 Nov;
28(10):1447-9.
PMID: 11688660
No abstract available.
10.
Oyen W, Witjes J, Corstens F
Eur Urol
. 2001 Oct;
40(3):294-9.
PMID: 11684845
Nuclear medicine techniques play an important role in (re)staging and treatment of prostate carcinoma patients. These techniques are reviewed in this paper. For many years, bone scanning has been a...